Some patients benefit from switching between injection and oral formulations to find the best tolerability profile
By starting with a high-purity product, reconstituting it correctly, choosing a thoughtful dosing strategy, and paying close attention to the response, you can conduct your research with confidence and generate data you can actually trust
The SURMOUNT-5 trial, published in the New England Journal of Medicine in 2025, randomly assigned 751 adults with obesity to either tirzepatide or semaglutide for 72 weeks.[1] The results were clear: Average weight loss with tirzepatide: 20.2% Average weight loss with semaglutide: 13.7% Tirzepatide patients were also more likely to hit major milestones 10%, 15%, 20%, and even 25% body weight loss
For instance, treating 20 type 2 diabetics with 35 mg PLP along with 3 mg activated folate and 2 mg vitamin B12 improved skin sensation in diabetic peripheral neuropathy (Walker 2010)
Home: Apply 12 mL to clean, dry scalp 12x daily (evening preferred)